Zobrazeno 1 - 10
of 94
pro vyhledávání: ''
Autor:
Jane E. Minturn, Ute Bartels, Nicholas G. Gottardo, Jordan R. Hansford, Christine Fuller, Cynthia Hawkins, Renee Doughman, Mariko DeWire-Schottmiller, Sarah Leary, Brooklyn Chaney, Blaise V. Jones, Michelle Monje-Deisseroth, James Roebker, Katherine E. Warren, Hetal Dholaria, Austin Schafer, Rachid Drissi, Adam Lane, Joshua J Baugh, Roger J. Packer, James L. Leach, Paul G. Fisher, Stewart Goldman, Stacie S. Wang, Maryam Fouladi, David S. Ziegler
Publikováno v:
Neuro Oncol
Abtract Background This study describes imaging features of diffuse intrinsic pontine glioma (DIPG) and correlates with overall survival (OS) and histone mutation status in the International DIPG Registry (IDIPGR). Methods Four hundred cases submitte
Autor:
Dieta Brandsma, Martin J. van den Bent
Publikováno v:
Neuro-Oncology, 22(5), 592-593. Oxford University Press
Autor:
Neeta Pandit-Taskar, Safiatu Diagana, Mark M. Souweidane, Kim Kramer, Sheila McThenia, Milan Grkovski, Maria Donzelli, Jeffrey P. Greenfield
Publikováno v:
Neuro-Oncology
Background Programmable ventriculoperitoneal (pVP) shunts are increasingly utilized for intraventricular chemotherapy, radioimmunotherapy, and/or cellular therapy. Shunt adjustments allow optimization of thecal space drug concentrations with minimiza
Autor:
Paul D. Brown, Daniel M. Trifiletti
Publikováno v:
Neuro-Oncology. 22:5-6
Autor:
Gereon R. Fink, Gabriele Stoffels, Karl-Josef Langen, Jan-Michael Werner, Caroline Tscherpel, Philipp Lohmann, Norbert Galldiks
Publikováno v:
Neuro Oncol
BACKGROUND Recent phase 2 data showed that the small molecule regorafenib with antiangiogenic properties has promising effectivity in glioblastoma patients at first progression. Following antiangiogenic therapy with bevacizumab, amino acid PET provid
Publikováno v:
Neuro-Oncology. 20:iii224-iii225
BACKGROUND: Various central nervous system tumors show different clinical behaviors in adult and pediatric patients. Intracranial meningiomas are the main cause of neurofibromatosis type 2 (NF2) patients’ death. It is very important to know well of
Autor:
Antonella Cacchione, Andrea Carai, Giovanna Stefania Colafati, Barbara Rombi, Maurizio Amichetti, Chiara Carducci, Angela Mastronuzzi, I Paul Voicu, Sabina Vennarini, Stefano Lorentini
Publikováno v:
Neuro-Oncology. 20:i177-i178
INTRODUCTION: Proton therapy (PT) is a radiation therapy in increasing use for paediatric cerebral tumours, as in medulloblastoma. Although publications to date are relatively limited, they however include cases of potential development of radionecro
Autor:
Francesco Barretta, Rita Balter, Lorenzo Genitori, Anna Mussano, Assunta Tornesello, Geraldina Poggi, Maura Massimino, Carlo Giussani, Felice Giangaspero, Antonio Ruggiero, Emilia Pecori, Carlo Efisio Marras, Paola Peretta, Francesca R. Buttarelli, Maria Luisa Garrè, Lorenza Gandola, Giuseppe Cinalli, Giovanni Scarzello, Luisa Chiapparini, Angela Mastronuzzi, Manila Antonelli, Piergiorgio Modena, Iacopo Sardi, Salvina Barra, Daniele Bertin, Veronica Biassoni, Massimo Caldarelli, Elisabetta Schiavello, Paolo Ferroli, Alessandra Erbetta, Luna Boschetti, P Bertolini, Maurizio Mascarin, Lucia Quaglietta, Milena La Spina, Elisabetta Viscardi
Publikováno v:
Neuro-Oncology. 20:i73-i74
Aims of patient follow-up are: discovering relapse to apply second-line therapy for possible cure, accruing patients in phase 1/2 protocols if second-line therapy is not standardized/curative, evaluating/treating iatrogenic effects. To lessen the pat
Autor:
Susan C Short, Andrew Scarsbrook, Luisa Ottobrini, John Wright, Joanna Koch-Paszkowski, Louise Murray, Gary Shaw, D Salvatore, Irvin Teh, Jürgen E. Schneider
Publikováno v:
Neuro Oncol
BACKGROUND Glioblastoma multiforme (GBM) carries a poor prognosis, partly due to biological and anatomical heterogeneity. Although radiotherapy (RT) is effective, high doses damage surrounding healthy tissues. Multimodal imaging with Magnetic Resonan
Publikováno v:
Neuro-Oncology. 19:vi152-vi153